Customers
See how our customers win with us.
- Industry: CDMO / CRO
- CYTENA instruments in use: UP.SIGHT™
- Cell type: HEK, CHO, iPSCs and Neural
Axxam is using the UP.SIGHT to generate monoclonal cell lines
SEE CASE STUDY
- Industry: CDMO
- CYTENA instruments in use: UP.SIGHT™
- Cell type: iPSC
Cellistic is using the CYTENA UP.SIGHT to generate monoclonal gene-edited iPSCs
SEE CASE STUDY
- Industry: Biopharma
- CYTENA instruments in use: Single Cell Printer™
- Cell type: CHO
Coupling CRISPR interference with FACS enrichment: New approach in glycoengineering of CHO cell lines for therapeutic glycoprotein production
ACCESS NOW
- Industry: Biopharma
- CYTENA instruments in use: F.SIGHT™
- Cell type: HEK293
Rapid lentiviral vector producer cell line generation using a single DNA construct
ACCESS NOW
- Industry: CDMO/CRO
- CYTENA instruments in use: F.SIGHT™
- Cell type: HEK293
A new T-antigen negative HEK293 cell line with improved AAV productivity
ACCESS NOW
- Industry: CDMO
- CYTENA instruments in use: B.SIGHT™
- Cell type: Pichia Pastoris
Lonza and CYTENA combine expertise to allow biotherapeutic manufacturers to benefit from the advantages of pichia pastoris as an expression system
ACCESS NOW
- Industry: Biopharma
- CYTENA instruments in use: F.SIGHT™
- Cell type: Human CD34+ Cells
Generation of stable suspension producer cell lines for serum-free lentivirus production
ACCESS NOW
- Industry: Biotech
- CYTENA instruments in use: Single Cell Printer™
- Cell type: CHO
Achieving greater efficiency and higher confidence in single-cell cloning by combining cell printing and plate imaging technologies
ACCESS NOW
- Industry: CDMO / CRO
- CYTENA instruments in use: UP.SIGHT™
- Cell type: HEK293
Establishment and Characterization of a Stable Producer Cell Line Generation Platform for the Manufacturing of Clinical-Grade Lentiviral Vectors
ACCESS NOW
- Industry: Biopharma
- CYTENA instruments in use: Single Cell Printer™
- Cell type: CHO
Targeted Locus Amplification and NGS combined with qPCR-based breakpoint analysis for the assurance of monoclonality in recombinant cell lines
ACCESS NOW
- Industry: Academic
- CYTENA instruments in use: Single Cell Printer™
- Cell type: iPSC
Longer metaphase and fewer chromosome segregation errors in modern human than Neanderthal brain development
ACCESS NOW
- Industry: CDMO/CRO
- CYTENA instruments in use: F.SIGHT™
- Cell type: CHO
Establishment of a CLD platform for generation of high titer CHO cell lines
ACCESS NOW
- Industry: CDMO/CRO
- CYTENA instruments in use: UP.SIGHT™ & C.STATION™
- Cell type: iPSCs
Using iPSC and gene editing technologies to generate immune-cloaked “off-the-shelf” allogeneic cell therapies
ACCESS NOW
- Industry: Academic
- CYTENA instruments in use: UP.SIGHT™
- Cell type: iPSCs
Single-cell cloning of human induced pluripotent stem cells
ACCESS NOW
- Industry: CDMO/CRO
- CYTENA instruments in use: UP.SIGHT™
- Cell type: CHO
Automation for dual clonality assurance and reduced timelines in CHO Cell Line Development
ACCESS NOW
- Industry: Biotech
- CYTENA instruments in use: F.SIGHT™
- Cell type: Histiocytic Lymphoma
scPICO: Achieving unprecedented single-cell sensitivity – a reference-free absolute quantitative assay of proteoforms
ACCESS NOW
- Industry: CDMO/CRO
- CYTENA instruments in use: F.SIGHT™
- Cell type: HEK293
Lentiviral vector packaging and producer 2 cell lines yield titres equivalent to the 3 industry-standard four-plasmid process
ACCESS NOW
- Industry: Academic
- CYTENA instruments in use: UP.SIGHT™
- Cell type: hESC
